92 related articles for article (PubMed ID: 10391237)
1. Alzheimer's disease. Pinning down phosphorylated tau.
Goedert M
Nature; 1999 Jun; 399(6738):739-40. PubMed ID: 10391237
[No Abstract] [Full Text] [Related]
2. The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein.
Lu PJ; Wulf G; Zhou XZ; Davies P; Lu KP
Nature; 1999 Jun; 399(6738):784-8. PubMed ID: 10391244
[TBL] [Abstract][Full Text] [Related]
3. Utilizing the peptidyl-prolyl cis-trans isomerase pin1 as a probe of its phosphorylated target proteins. Examples of binding to nuclear proteins in a human kidney cell line and to tau in Alzheimer's diseased brain.
Thorpe JR; Morley SJ; Rulten SL
J Histochem Cytochem; 2001 Jan; 49(1):97-108. PubMed ID: 11118482
[TBL] [Abstract][Full Text] [Related]
4. Pin1: a new outlook in Alzheimer's disease.
Lonati E; Masserini M; Bulbarelli A
Curr Alzheimer Res; 2011 Sep; 8(6):615-22. PubMed ID: 21605045
[TBL] [Abstract][Full Text] [Related]
5. Pin1 colocalization with phosphorylated tau in Alzheimer's disease and other tauopathies.
Ramakrishnan P; Dickson DW; Davies P
Neurobiol Dis; 2003 Nov; 14(2):251-64. PubMed ID: 14572447
[TBL] [Abstract][Full Text] [Related]
6. Tau as a drug target in Alzheimer's disease.
Gozes I
J Mol Neurosci; 2002 Dec; 19(3):337-8. PubMed ID: 12540061
[No Abstract] [Full Text] [Related]
7. Pin1 promotes degradation of Smad proteins and their interaction with phosphorylated tau in Alzheimer's disease.
Ueberham U; Rohn S; Ueberham E; Wodischeck S; Hilbrich I; Holzer M; Brückner MK; Gruschka H; Arendt T
Neuropathol Appl Neurobiol; 2014 Dec; 40(7):815-32. PubMed ID: 24964035
[TBL] [Abstract][Full Text] [Related]
8. Pin1 allows for differential Tau dephosphorylation in neuronal cells.
Hamdane M; Dourlen P; Bretteville A; Sambo AV; Ferreira S; Ando K; Kerdraon O; Bégard S; Geay L; Lippens G; Sergeant N; Delacourte A; Maurage CA; Galas MC; Buée L
Mol Cell Neurosci; 2006; 32(1-2):155-60. PubMed ID: 16697218
[TBL] [Abstract][Full Text] [Related]
9. Pin1: a therapeutic target in Alzheimer neurodegeneration.
Hamdane M; Smet C; Sambo AV; Leroy A; Wieruszeski JM; Delobel P; Maurage CA; Ghestem A; Wintjens R; Bégard S; Sergeant N; Delacourte A; Horvath D; Landrieu I; Lippens G; Buée L
J Mol Neurosci; 2002 Dec; 19(3):275-87. PubMed ID: 12540053
[TBL] [Abstract][Full Text] [Related]
10. Distinct functions of cis and trans phosphorylated tau in Alzheimer's disease and their therapeutic implications.
Nakamura K; Zhou XZ; Lu KP
Curr Mol Med; 2013 Aug; 13(7):1098-109. PubMed ID: 23157676
[TBL] [Abstract][Full Text] [Related]
11. Protein twists and turns in Alzheimer disease.
Maudsley S; Mattson MP
Nat Med; 2006 Apr; 12(4):392-3. PubMed ID: 16598285
[No Abstract] [Full Text] [Related]
12. Pin1 flips Alzheimer's switch.
Etzkorn FA
ACS Chem Biol; 2006 May; 1(4):214-6. PubMed ID: 17163675
[TBL] [Abstract][Full Text] [Related]
13. Aging as a Precipitating Factor in Chronic Restraint Stress-Induced Tau Aggregation Pathology, and the Protective Effects of Rosmarinic Acid.
Shan Y; Wang DD; Xu YX; Wang C; Cao L; Liu YS; Zhu CQ
J Alzheimers Dis; 2016; 49(3):829-44. PubMed ID: 26577520
[TBL] [Abstract][Full Text] [Related]
14. The significance of Pin1 in the development of Alzheimer's disease.
Wang S; Simon BP; Bennett DA; Schneider JA; Malter JS; Wang DS
J Alzheimers Dis; 2007 Mar; 11(1):13-23. PubMed ID: 17361031
[TBL] [Abstract][Full Text] [Related]
15. Proline-directed phosphorylation and isomerization in mitotic regulation and in Alzheimer's Disease.
Lu KP; Liou YC; Vincent I
Bioessays; 2003 Feb; 25(2):174-81. PubMed ID: 12539244
[TBL] [Abstract][Full Text] [Related]
16. Configuration-specific immunotherapy targeting cis pThr231-Pro232 tau for Alzheimer disease.
Wang JZ; Zhang Y
J Neurol Sci; 2015 Jan; 348(1-2):253-5. PubMed ID: 25467137
[TBL] [Abstract][Full Text] [Related]
17. Pin1 Knockout Mice: A Model for the Study of Tau Pathology in Alzheimer's Disease.
Kondo A; Albayram O; Zhou XZ; Lu KP
Methods Mol Biol; 2017; 1523():415-425. PubMed ID: 27975268
[TBL] [Abstract][Full Text] [Related]
18. Pin-pointing APP processing.
Willnow TE; Andersen OM
Mol Interv; 2006 Jun; 6(3):137-9. PubMed ID: 16809474
[No Abstract] [Full Text] [Related]
19. [Prolyl isomerase pin1 protecting against aging diseases].
Uchida T; Fanghaenel J; Uchida C; Ostroff L
Tanpakushitsu Kakusan Koso; 2005 Sep; 50(11):1413-9. PubMed ID: 16146189
[No Abstract] [Full Text] [Related]
20. Proline isomer-specific antibodies reveal the early pathogenic tau conformation in Alzheimer's disease.
Nakamura K; Greenwood A; Binder L; Bigio EH; Denial S; Nicholson L; Zhou XZ; Lu KP
Cell; 2012 Mar; 149(1):232-44. PubMed ID: 22464332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
